Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infliximab”

419 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 419 results

Not applicableStudy completedNCT07263477
What this trial is testing

A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of Infliximab

Who this might be right for
Crohn Disease (CD)
Second Affiliated Hospital of Wenzhou Medical University 900
Post-approval studies (Phase 4)Study completedNCT04982172
What this trial is testing

Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases

Who this might be right for
Inflammatory Bowel Diseases
Universitaire Ziekenhuizen KU Leuven 80
Testing effectiveness (Phase 2)Looking for participantsNCT02638701
What this trial is testing

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

Who this might be right for
AneurysmStrokeVasculitis+1 more
University of California, San Francisco 8
Not applicableStudy completedNCT00327275
What this trial is testing

The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University of Arizona 35
Not applicableNot Yet RecruitingNCT07314606
What this trial is testing

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

Who this might be right for
Crohn Disease (CD)IBD (Inflammatory Bowel Disease)IBD - Inflammatory Bowel Disease
University of British Columbia 140
Not applicableUnknownNCT03769987
What this trial is testing

Registry for Advanced Sarcodiosis

Who this might be right for
Sarcoidosis
University of Cincinnati 800
Early research (Phase 1)Study completedNCT04779892
What this trial is testing

The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety

Who this might be right for
Rheumatoid Arthritis
Taizhou Mabtech Pharmaceutical Co.,Ltd 90
Large-scale testing (Phase 3)Study completedNCT00095147
What this trial is testing

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 431
Post-approval studies (Phase 4)Ended earlyNCT01783015
What this trial is testing

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 16
Early research (Phase 1)Study completedNCT01844804
What this trial is testing

A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)

Who this might be right for
Healthy
Pfizer 146
Not applicableStudy completedNCT00705614
What this trial is testing

Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)

Who this might be right for
Crohn's Disease
Merck Sharp & Dohme LLC 2,662
Post-approval studies (Phase 4)Study completedNCT01346826
What this trial is testing

Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Asan Medical Center 145
Post-approval studies (Phase 4)Looking for participantsNCT04999228
What this trial is testing

Top Down Versus Step up in Pediatric Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInfliximabChildren
Children's Hospital of Fudan University 40
Not applicableStudy completedNCT03885037
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Who this might be right for
Rheumatoid Arthritis
Pfizer 77
Testing effectiveness (Phase 2)Study completedNCT00074074
What this trial is testing

Infliximab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 46
Testing effectiveness (Phase 2)UnknownNCT00244179
What this trial is testing

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Who this might be right for
Reactive Arthritis
Charite University, Berlin, Germany 40
Large-scale testing (Phase 3)Study completedNCT02762812
What this trial is testing

Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Biocad 199
Testing effectiveness (Phase 2)Active Not RecruitingNCT05034536
What this trial is testing

PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Massachusetts General Hospital 36
Not applicableUnknownNCT02852850
What this trial is testing

In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shandong University 30
Not applicableStudy completedNCT04312659
What this trial is testing

Infliximab in the Treatment of Chinese Children With Crohn's Disease

Who this might be right for
Crohn Disease
Johnson & Johnson (China) Investment Ltd. 38
Load More Results